✦ LIBER ✦

Meditation Reduces Sympathetic Activation and Improves the Quality of Life in Elderly Patients with Optimally Treated Heart Failure: A Prospective Randomized Study

✍ Scribed by Curiati, José Antonio; Bocchi, Edimar; Freire, José Octávio; Arantes, Ana Claudia; Braga, Márcia; Garcia, Yolanda; Guimarães, Guilherme; Fo, Wilson Jacob

Book ID: 120502617
Publisher: Mary Ann Liebert
Year: 2005
Tongue: English
Weight: 160 KB
Volume: 11
Category: Article
ISSN: 1075-5535
DOI: 10.1089/acm.2005.11.465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of a randomised con

Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study protocol

✍ Ana Zuazagoitia; Gonzalo Grandes; Jesús Torcal; Iñaki Lekuona; Pilar Echevarria; 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 423 KB

The effects of a high-caloric protein-ri

The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study

✍ Piotr Rozentryt; Stephan von Haehling; Mitja Lainscak; Jolanta U. Nowak; Kamyar 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 168 KB

Improved Quality of Life (QOL) Outcomes

Improved Quality of Life (QOL) Outcomes in Patients With Head-and-Neck Squamous Cell Carcinoma (HNSCC) Treated With Intensity Modulated Radiation Therapy (IMRT) Compared to 3-dimensional Conformal Radiation Therapy (3D-CRT): Evidence From a Prospective Randomized Study

✍ Agarwal, J.; Rathod, S.; Murthy, V.; Ghosh-laskar, S.; Budrukkar, A.; Dinshaw, K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB